February 15, 2023

Junshi Biosciences and Coherus Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

– Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with toripalimab plus chemotherapy significantly prolongs survival in patients with advanced NPC – SHANGHAI, China and REDWOOD CITY, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences

Read More

100 Days to Go Until Vivid Sydney Dazzles Again

Vivid Sydney SYDNEY, Feb. 15, 2023 (GLOBE NEWSWIRE) — The countdown to Vivid Sydney 2023 has officially begun, with today marking 100 days until the festival’s Lights On moment at 6 p.m. on Friday, 26 May (AEST). Celebrating creativity, innovation

Read More

Report Says US Justice Department Escalates Apple Probe

The United States Justice Department has in recent months escalated its antitrust probe on Apple Inc., The Wall Street Journal reported on Wednesday citing people familiar with the matter.Reuters had previously reported the Justice Department opened an…

Read More